medac GmbH Company Profile

News Articles [ 10 Associated News Articles listed on BioPortfolio]

Kam Aims Uses Cloud Technology to Bring Affordable Solution to Freestanding Ambulatory Surgery Centers

AUGUSTA, Ga., July 26, 2012 /PRNewswire-iReach/ -- Medac, the parent company of Kam Technologies, and a leading provider of anesthesia billing, practice management, and technology solutions nationwide...

Myconostica announces successful continuation of D round with investment by Medac

Myconostica Ltd, the UK-based medical diagnostic company developing and commercialising rapid and highly specific tests for life-threatening fungal infections, today announces the completion of an inv...

Pending EC decision: Capecitabine medac , capecitabine, Opinion date: 20-Sep-2012

Pending EC decision: Capecitabine medac, capecitabine, Opinion date: 20-Sep-2012

Human medicines European Public Assessment Report (EPAR): Capecitabine Medac, capecitabine, Revision: 1, Authorised

Human medicines European Public Assessment Report (EPAR): Leflunomide medac, leflunomide, Revision: 5, Authorised

Human medicines European Public Assessment Report (EPAR): Capecitabine Medac, capecitabine, Revision: 0, Authorised

Human medicines European Public Assessment Report (EPAR): Leflunomide medac, leflunomide, Revision: 4, Authorised

Drugs and Medications [0 Results]

None

PubMed Articles [ 1 Associated PubMed Articles listed on BioPortfolio]

Population pharmacokinetics of native Escherichia coli asparaginase.

The main aim of this analysis was to characterize the population pharmacokinetics of native Escherichia coli asparaginase (ASNase medac™) in pediatric patients with previously untreated acute lympho...

Clinical Trials [ 2 Associated Clinical Trials listed on BioPortfolio]

SentoClone® Compared to Reference Treatment in Advanced Malignant Melanoma

The purpose of this study is to elucidate whether SentoClone® gives improved treatment responses in patients with advanced malignant melanoma in comparison to established reference treatm...

Comparative Efficacy and Safety of Two Asparaginase Preparations in Children With Previously Untreated Acute Lymphoblastic Leukaemia

This multicentric phase III study is designed to assess the efficacy and safety of recombinant asparaginase (rASNase) in comparison to Asparaginase medac™ during treatment of children wi...

Companies [ 1 Associated Companies listed on BioPortfolio]

medac GmbH

Nil